Contents
Download PDF
pdf Download XML
297 Views
256 Downloads
Share this article
Research Article | Volume 14 Issue:1 (Jan-Feb, 2024) | Pages 404 - 412
Assessment of Type II Diabetes Medication and Its drug-related Adverse effects
 ,
1
Assistant Professor, Department of General Medicine, Ayaan Institute of Medical Sciences, Kanakamamidi (v), Ranga reddy District, Telangana State Pin-501504
2
Associate Professor, Department of General Medicine, Ayaan Institute of Medical Sciences, Kanakamamidi (v), Ranga reddy District, Telangana State Pin-501504
Under a Creative Commons license
Open Access
Received
Oct. 24, 2023
Revised
Nov. 8, 2023
Accepted
Nov. 30, 2023
Published
Dec. 12, 2023
Abstract

Background: 

Background: Assessing a patient with Type 2 Diabetes (T2DM) involves a comprehensive evaluation of their medical history, current symptoms, physical examination, and laboratory tests. Here's a structured approach to assessing a patient with T2DM. Evaluate the patient's current diabetes management plan, including diet, exercise, medication adherence, self-monitoring of blood glucose, and insulin administration if applicable. Assess barriers to effective diabetes management, such as socioeconomic factors, access to healthcare, health literacy, and psychosocial support. Collaborate with the patient to set individualized goals for glycemic control, blood pressure, lipid levels, weight management, and prevention of diabetes-related complications. Materials and methods: A six-month longitudinal study was conducted at a tertiary care facility. Those with type 2 diabetes who were receiving insulin and oral hypoglycemics were included in the trial. Laboratory investigations and a sociodemographic profile were gathered using a pretested, structured questionnaire. EPI Info, Open EPI, and SPSS 22 version software were used for the statistical analysis. The statistical tests were the Students t-test and the Chi-square test. Result: There were ninety-nine diabetic individuals in the oral group. Oral hypoglycemics were 46.8±7.6 years old on average. Our research indicates that type II diabetes can be treated with both monotherapy and combination medications. According to the results of this study, the majority of doctors first prescribed monotherapy (25%) consisting of Metformin, Glipizide, Glimepiride, and Gliclazide to control hyperglycemia. Then came triple treatment (40%) including Metformin + Glimepiride + Pioglitazone and dual therapy (35%) comprising FDC of Metformin + Pioglitazone, Metformin + Glipizide, Metformin + Glimepiride, Metformin + Saxagliptin, and Metformin + Voglibose. Conclusion: The most often given medications in our research were biguanide, metformin, and sulfonylureas, such as glimepiride, glibenclamide, glipizide, and gliclazide.

Keywords
Recommended Articles
Research Article
Electrical and haemodynamic changes in heart of patient with chronic obstructive lung diseases
...
Published: 07/10/2025
Download PDF
Research Article
Screening of methicillin-resistant Staphylococcus aureus (MRSA) in patients and health care workers and its susceptibility to mupirocin and vancomycin in a tertiary care teaching hospital of West Bengal
...
Published: 28/05/2025
Download PDF
Research Article
Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
Published: 30/06/2019
Download PDF
Research Article
Transport Risk Index of Physiologic Stability as a Predictor of Short-Term Outcomes in Critically Ill Transported Neonates: A Prospective Observational Study
...
Published: 30/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.